#¼Ûµµ»êÈÄdz, #¼Ûµµ»êÈÄdzġ·á, #»ý¸®Àü°¡½¿ÅëÁõ, #¼Ûµµ»ý¸®Àü°¡½¿ÅëÁõ, #»êÈÄdzġ·á, #»ý¸®Àü°¡½¿ÅëÁõÄ¡·á, #¼Ûµµ»ý¸®Àü°¡½¿ÅëÁõ, #±¸¿ùµ¿»êÈÄdz
¼Ûµµ»êÈÄdz,,¼Ûµµ»êÈÄdzġ·á,,»ý¸®Àü°¡½¿ÅëÁõ,,¼Ûµµ»ý¸®Àü°¡½¿ÅëÁõ,,»êÈÄdzġ·á,,»ý¸®Àü°¡½¿ÅëÁõÄ¡·á,,¼Ûµµ»ý¸®Àü°¡½¿ÅëÁõ,,±¸¿ùµ¿»êÈÄdz
¾È³çÇϼ¼¿ä. ¼Ûµµ»êÈÄdz ±¸¿ùµ¿ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä
¼Ûµµ»êÈÄdz ±¸¿ùµ¿ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ¼ÛµµÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â»ý¸®Àü°¡½¿ÅëÁõ, ³ÀÓÇѹæÄ¡·á, ½ÃÇè°ü¾Æ±â, ÈÇÐÀûÀ¯»êÇÏÇ÷, »êÈÄÅëÁõ, ´ÙÀ̾îÆ®»ý¸®ºÒ¼ø, »ý¸®Àü±¸¿ªÁú, 20´ëÀڱñÙÁ¾, ¼ÒÆļúÈĸöÁ¶¸®, ¼ø»êÇѾà, Áúĵð´ÙÁõ, ºÒÀÓÇѾà, ÀڱñÙÁ¾»ý¸®Åë, ÀÓ½ÅÁغñÇѾà, ĵð´ÙÁú¿°³¿»õ, Ãâ»êÇѾà, ³ÀÓÄ¡·á, ³ÀÓÇѾà, »ý¸®ÁÖ±âºÒ±ÔÄ¢, »ý¸®½Ä¿åÀúÇÏ, »ý¸®ÀüÁõÈıº, Àڱù°È¤, »ý¸®ÀüÁõÈıºµÎÅë, ¸¸¼ºÁú¿°, »ý¸®Àü¹è¾ÆÇÄµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù.
¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó ½Å°æ±ÙÀ°Àü±âÀÚ±Ø, FES, ½½¸µ¿îµ¿, Çâ±â¿ä¹ý, ÀÌħ, silver spike point, °æÇÇÀûÀü±â½Å°æÀÚ±ØÄ¡·á, °æÃßÃß³ª, ¾È¸é°èÃø¹æ¹ý¿¡ ÀÇÇÑ Ã¼Çü°Ë»ç, ºÀ¾àħ, Çѹ湰¸®¿ä¹ý, Àü±âÀÚ±ØÄ¡·á, ÇÑ·©Ä¡·á, ÆĶóÇÉ¿å, ·¹ÀÌÀú, ³Ã¿Â¿å, µµÀο¿ä¹ý, ¼öÁöħ, ¾È¸é°èÃø°Ë»ç, ¾à¹°¿ä¹ý, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù
¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼ Áø·áÁßÀÌ¸ç ºÎ»ê ºÎ»êÁø±¸ ¹üõ2µ¿, ¿ï»ê ³²±¸ Ȳ¼ºµ¿, °æ±â ȼº½Ã ¿ìÁ¤À¾, °æ³² Å뿵½Ã ¿ë³²¸é, Àü³² °Áø±º µµ¾Ï¸é, Á¦ÁÖ ¼±ÍÆ÷½Ã Áß¹®µ¿, ºÎ»ê ¼±¸ ºÎ¹Îµ¿1°¡, Ãæ³² ¼Ãµ±º ºñÀθé, Àü³² °íÈﱺ ¿µ³²¸é, ÀüºÏ ÀüÁֽà ¿Ï»ê±¸ µ¿¿Ï»êµ¿, °æ³² Å뿵½Ã Å뿵¿ìü±¹»ç¼ÇÔ, °æ±â ¿©ÁÖ±º °Ãµ¸é, °æ³² ÀǷɱº ºÀ¼ö¸é, Àü³² ¸ñÆ÷½Ã ¹«¾Èµ¿, °¿ø °¸ª½Ã Æ÷³²2µ¿, °æ±â ¾çÁֽà ´ö°èµ¿, °æ³² â¿ø½Ã ÁøÇر¸ ´ëÁ×µ¿, °æºÏ ÀǼº±º ´Ü¹Ð¸é, °æ±â µ¿µÎõ½Ã »óºÀ¾Ïµ¿, Ãæ³² ¼»ê½Ã °íºÏ¸é, °æ³² »çõ½Ã »ç³²¸é, °æºÏ °æÁֽà µµÁöµ¿, ÃæºÏ Á¦Ãµ½Ã °í¸íµ¿, ¿ï»ê ºÏ±¸ âÆòµ¿, ÀüºÏ Áø¾È±º µ¿Çâ¸é, °¿ø µ¿Çؽà ´ë±¸µ¿, °æ³² ÇÕõ±º ´ë¾ç¸é, ÀüºÏ ¹«ÁÖ±º ¾È¼º¸é, °æ±â Àǿսà °íõµ¿, Àü³² ¸ñÆ÷½Ã Á×±³µ¿, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼ ³»¿øÇÏ°í °è½Ê´Ï´Ù
¼Ûµµ»êÈÄdzġ·á ãÀ¸½Ã´Â Áß±¸, ¸Å¼Û¸é, ¿¬¼öµ¿, ¼Ûµµ±¹Á¦µµ½Ã, µµÈµ¿, ¿µÁ¾Çϴõµ½Ã, ¹è°ð, °¡Á¤µ¿, ¼þÀǵ¿, ³²µ¿±¸, ½ÃÈï, Áßµ¿, °¡Áµ¿, û¶ó, ºÀ´ãÀ¾, ½ÃÈ, µ¿Ãᵿ, °ü±³µ¿, ³²±¸, ¿µÁ¾µµ, ¸¶µµ¸é, ¿¬¼ö±¸, ÀÎõ, ¼Û»ê¸é, ¼Û¸²µ¿, ÀÎõ³íÇöµ¿, Á־ȿª, ¿µÈïµµ, µ¿ÀÎõ, ¹®Çе¿, °£¼®µ¿, À²¸ñµ¿, ¼Ûµµ½Åµµ½Ã, ¼±Çе¿, µµ¸²µ¿ µî ¼Ûµµ Áö¿ª Áֹε鲲¼ ¹Ì¿ÃÇÑÀÇ¿ø¼ÛµµÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù.
´õ »ìÆ캸±â
1. As-Sanie S, Harris RE, Napadow V, et al. Changes in regional gray matter volume in women with chronic pelvic pain: a voxel-based morphometry study. Pain 2012; 153:1006.
2. ESHRE Task Force on Ethics and Law, including, Dondorp W, de Wert G, et al. Lifestyle-related factors and access to medically assisted reproduction. Hum Reprod 2010; 25:578.
3. Anglesio MS, Papadopoulos N, Ayhan A, et al. Cancer-Associated Mutations in Endometriosis without Cancer. N Engl J Med 2017; 376:1835.
4. Missmer SA, Chavarro JE, Malspeis S, et al. A prospective study of dietary fat consumption and endometriosis risk. Hum Reprod 2010; 25:1528.
5. Pall M, Fridén BE, Brännström M. Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study. Hum Reprod 2001; 16:1323.
6. Cibula D, Sindelka G, Hill M, et al. Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin. Hum Reprod 2002; 17:76.
7. Ziaei S, Faghihzadeh S, Sohrabvand F, et al. A randomised placebo-controlled trial to determine the effect of vitamin E in treatment of primary dysmenorrhoea. BJOG 2001; 108:1181.
8. Kavoussi SK, Odenwald KC, As-Sanie S, Lebovic DI. Incidence of ovarian endometrioma among women with peritoneal endometriosis with and without a history of hormonal contraceptive use. Eur J Obstet Gynecol Reprod Biol 2017; 215:220.